AzTrials
AzTrials

Pregnancy RelatedFMASDNCT05253742

Fetal MRI Acquisition and Sequence Development

An observational study of Pregnancy Related, run by Massachusetts General Hospital.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Testing of new magnetic resonance imaging (MRI) pulse sequences (image acquisition software) for imaging the fetus to improve workflow and image quality in fetal imaging and diagnosis. The investigators would like to develop novel MRI approaches to enhance fetal imaging with MRI, in the presence of motion. Read more about this study

Who is it for?
Ages 13 to 40 weeksHealthy volunteers can take part
Conditions the study is for
Pregnancy Related
How many people
0 participants
Where
No sites listed yet
Study dates
31 May 2023to 31 May 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 40 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Pregnant women presenting for imaging of the fetus

Eligibility will be determined prior to the scan session by a pre-screening interview conducted either via telephone or in person asking about MR contraindications.

Participants will be excluded from study entry or study completion when any of the following exclusion criteria are met at any time of screening or enrollment:

  • Claustrophobia sufficient to interfere with MRI or render the subject unable to complete an MRI scan
  • MRI contraindications (e.g., magnetically or mechanically activated implants)
  • Weight greater than or equal to 300lbs (weight limit of the MRI table)
  • Non-English speaking
  • Neurological conditions (i.e. epilepsy, multiple sclerosis, neurodegenerative diseases, memory disorders, brain tumor)
  • Past incidence of stroke or heart attack
  • Severe hypertension, blood disorders, advanced diabetes mellitus, or advanced cardiovascular disease
  • Hospitalization within 6 weeks prior to enrollment
  • Significant acute and/or chronic medical conditions, current use of medications that indicate the existence of significant medical conditions, and other unspecified reasons that make the subject unsuitable for enrollment at the discretion at the PI and a consulting MD.

Pregnant mothers with the following features will be excluded.

  • Mothers with contraindication to MRI (such as pacemaker, metal in body, exceeding scanner weight or bore diameter limits (550lbs, 70cm))
  • Mothers with claustrophobia
  • Mothers medically unstable for the MRI study

About this study

Testing of new magnetic resonance imaging (MRI) pulse sequences (image acquisition software) for imaging the fetus to improve workflow and image quality in fetal imaging and diagnosis. The investigators would like to develop novel MRI approaches to enhance fetal imaging with MRI, in the presence of motion. As part of technical development, the investigators plan to develop methods to improve structural T1 and T2 weighted images, MR angiography, diffusion and spectroscopy measurements of the fetus.

Read the detailed description

Fetal MRI has become a critical tool for both studying the early development of the human brain and resolving diagnostic ambiguities that may remain after routine ultrasound exams. Due to its excellent soft-tissue contrast and the absence of harmful ionizing radiation, MRI is preferable to computed tomography for neuroimaging. Unfortunately, fetal and maternal motion limit fetal MRI to rapid two-dimensional (2D) sequences with thick slices such as half-Fourier single-shot turbo spin echo (HASTE). Although these sequences decrease the impact of motion during the sub-second acquisition of individual slices, multiple slices are needed, and contiguous orthogonal scans are challenging as motion occurs between slices. Typically, >38% of acquisitions are discarded because of corrupted geometry and artifacts.

In this project the investigators will develop software that runs on the Siemens MRI scanner. This software will improve the workflow for fetal imaging i.e. for imaging the fetus in utero. Fetal imaging in its current form is inefficient due to the frequent motion of the fetus during the imaging procedure. In this project the investigators will develop automated methods for alignment and tracking of the fetus during imaging, to more efficiently image the fetus and to obtain better image quality in a shorter examination. The investigators are specifically interested in the fetal brain, but these methods may be generalized to all fetal organ systems. The investigators will install the software on the scanner and test these methods with volunteers.

Being tested
No intervention - the investigators are evaluating a new image acquisition method on an MRI scanner
Keywords
MRI, Fetus, Uterus, Placenta, Brain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No intervention - the investigators are evaluating a new image acquisition method on an MRI scannerOther

    The investigators will evaluate the performance of a modified MRI acquisition method against an existing method in fetal imaging in volunteers

Study groups in NCT05253742
Study groupRoleWhat they receive
Pregnant women presenting for MRIAlternative motion-robust MR imaging sequences and procedures for automatic positioning while be tested during fetal brain imaging
Receives: Other: No intervention - the investigators are evaluating a new image acquisition method on an MRI scanner

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Image alignment in fetal MRI

    Evaluation of image alignment with automatical positioning in MRI

    Measured: Five year K99/R00 project

  2. Tracking quality in fetal MRI

    Evaluation of image quality with motion tracking in MRI

    Measured: Five year K99/R00 project

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2022
  2. Study start31 May 2023 (estimated)
  3. Primary completion31 May 2026 (estimated)
  4. Study completion31 May 2026 (estimated)

Why it stopped: The investigator decided to use existing data sets rather than to collect new data.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05253742
Sponsor's protocol ID
2021P001433
Acronym
FMASD
Status last verified
Jun 2026
First submitted
11 Jan 2022
Last updated
11 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The investigators will share data if requested as permitted by the Massachusetts General Brigham (MGB) Institutional Review Board (IRB).

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy Related, run by Massachusetts General Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Image alignment in fetal MRI (time frame: Five year K99/R00 project). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in